➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Colorcon
Dow
McKinsey
AstraZeneca

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Talimogene laherparepvec - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for talimogene laherparepvec
Tradenames:1
Patents:5
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for talimogene laherparepvec
Recent Clinical Trials for talimogene laherparepvec

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of California, DavisPhase 2
Assistance Publique - Hôpitaux de ParisPhase 2
Angela N Fellner PhD CCRPPhase 2

See all talimogene laherparepvec clinical trials

Patent Text Search: US Patents for talimogene laherparepvec

These patents were identified by searching patent claims
Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen Inc IMLYGIC talimogene laherparepvec INJECTION, SUSPENSION 125518 1 2015-11-02   Start Trial AMGEN INC. (Thousand Oaks, CA) 2033-08-30 search
Amgen Inc IMLYGIC talimogene laherparepvec INJECTION, SUSPENSION 125518 1 2015-11-02   Start Trial Amgen Inc. (Thousand Oaks, CA) 2032-08-30 search
Amgen Inc IMLYGIC talimogene laherparepvec INJECTION, SUSPENSION 125518 1 2015-11-02   Start Trial Advenchen Pharmaceuticals, LLC (Moorpark, CA) 2035-05-04 search
Amgen Inc IMLYGIC talimogene laherparepvec INJECTION, SUSPENSION 125518 1 2015-11-02   Start Trial Advenchen Pharmaceuticals, LLC (Moorpark, CA) 2035-05-04 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Merck
Mallinckrodt
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group

DrugPatentWatch reviews